๐—Ÿ๐—ผ๐—ป๐—ด ๐—ง๐—ฒ๐—ฟ๐—บ ยฎโ„ข
19.8K subscribers
287 photos
3 files
17 links
In this Long term call monthly 1-3 call given holding period 1-3yrs
More premium Multibagger jackpot call msg me @Shortterm_bot

I am not SEBI registered analyst All the stocks are educational purpose,consulting your financial advisor before buying
Download Telegram
๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ž ๐ข๐ง ๐…๐ˆ๐ˆ ๐š๐ง๐ ๐ƒ๐ˆ๐ˆ ๐ฌ๐ญ๐š๐ค๐ž๐ฌ!

Top 15 Stocks with Increased FII and DII Holdings!๐ŸŽฏ๐Ÿ“Š

1-Indigo Paints Ltd
2-Cyient DLM Ltd
3-Hi-Tech Pipes Ltd
4-Zen Technologies Ltd
5-Medi Assist Healthcare Services Ltd
6-Shaily Engineering Plastics Ltd
7-Electronics Mart India Ltd
8-Bharat Bijlee Ltd
9-Glenmark Life Sciences Ltd
10-Techno Electric & Engineering Company Ltd
11-5-Gulf Oil Lubricants India Ltd
12-Welspun Corp Ltd
13-PVR Inox Ltd
14-Welspun Living Ltd
15-Ethos Ltd
๐Ÿ‘16โšก11๐Ÿ”ฅ7๐Ÿ‘Œ3โค2
Good morning
๐Ÿ‘5๐Ÿ†’4๐Ÿ•Š1๐Ÿพ1๐Ÿ˜‡1
Stocks to Buy for an Upside Potential of upto 58%

1โƒฃ Timken India
Target Price: โ‚น4080
Upside Potential: 23%
Recommended by: ICICI Direct

2โƒฃ L&T Finance
Target Price: โ‚น200
Upside Potential: 42%
Recommended by: ICICI Securities

3โƒฃ Ambuja Cements
Target Price: โ‚น710
Upside Potential: 44%
Recommended by: Motilal Oswal Financial Services

4โƒฃ Astral
Target Price: โ‚น2666
Upside Potential: 49%
Recommended by: Anand Rathi
๐Ÿ‘22๐Ÿ‘Œ6โค4๐Ÿ”ฅ3โšก1
Good morning
๐Ÿ•Š4๐Ÿ†’2๐Ÿ‘1๐Ÿ”ฅ1
CRISIL Company report

CRISIL (Credit Rating Information Services of India Limited) was incorporated in 1987. It is Indiaโ€™s foremost provider of ratings, data, research, analytics, and solutions. They operates their business from India, United States (US), United Kingdom (UK), Argentina, Poland, China, Hong Kong, Singapore and United Arab Emirates (UAE). It is owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics & data to the capital and commodity markets worldwide. It serves clients ranging from MSME to large corporates, investors and top global financial institutions. They also work with governments & policy makers in the infrastructure space in India and other emerging markets. It help clients manage and mitigate risks, take pricing and valuation decisions, reduce time to market, generate more revenue, and enhance returns. By helping shape public policy on infrastructure in emerging markets, CRISIL helps catalyze economic growth and development in these geographies. The company has three business segments1) Research- Research segment includes global research and risk solutions, industry reports, customized research assignments, subscription to data services, independent equity research (IER), IPO gradings and training. 2) Ratings- Ratings services includes credit ratings for corporates, banks, bank loans, small and medium enterprises (SME), credit analysis services, grading services and global analytical services. 3) Advisory- It provides advisory services and a comprehensive range of risk management tools, analytics and solutions to financial institutions, banks and corporates in India.
๐Ÿ‘8๐Ÿ”ฅ3โšก2๐Ÿ‘Œ1
#SALES #GROWTH 5 Year CAGR 12.4%

In CY23, the sales increased by 13% YoY to โ‚น3,140 cr, driven by growth in both ratings and research business by 16% and 12%, respectively. The bond issuances declined in H2 CY23, on account of increasing geopolitical uncertainties and the consequent hardening of bond yields. Both the global divisions witnessed growth amidst pressure on discretionary spends by financial services clients. GR&RS (Global Research & Risk Solutions) division saw traction in lending and buyside segment, while GBA (Global Benchmarking Analytics) saw momentum in CIB, driven by emphasis on client engagement. In 9M CY24, the sales increased by 5.6% YoY to โ‚น2,347 cr, largely driven by momentum in bond issuances and bank loan ratings. However, research division was impacted on account of slowdown in the discretionary spendings.
โšก5๐Ÿ‘3๐Ÿ”ฅ2โค1๐Ÿ‘1
#EBITDA #GROWTH 5 Year CAGR 13.5%

During CY23, the EBITDA stood at โ‚น881 cr, a growth of 20.7% YoY. The major expenses mainly comprised of employee benefit expense and other expenses. During 9M CY24, the EBITDA stood at โ‚น623 cr, recording a growth of 3.9% YoY on account of increase in other expenses.
๐Ÿ”ฅ5๐Ÿ‘3โšก1๐Ÿ‘Œ1
#PAT #GROWTH 5 Year CAGR 12.6%

During CY23, the PAT stood at โ‚น658 cr, recording a growth of 17% YoY. The impact of foreign exchange movement was not favorable as compared with the same period last year. During 9M CY24, the PAT stood at โ‚น459 cr, recording a growth of 2.4% YoY. The effective tax rate of the company inched up on account of increase in tax rates in one of the ex-India jurisdictions.
๐Ÿ‘7๐Ÿ”ฅ3โšก1
#Management

Mr. Yann Le Pallec is Executive Managing Director and Global Head of Ratings for S&P Global Ratings. He oversees a group of 2,200 analysts and support staff present in 28 countries and covering more than one million outstanding ratings on entities and securities across a wide range of sectors including governments, corporations, financial institutions and structured finance. Amish Mehta is the MD and CEO of CRISIL. He leads CRISILโ€™s Indian and global businesses, steering its efforts to deliver high-quality analytics, opinions & solutions to corporations, investors, financial institutions, governments. policymakers and The management believes that the two pillars of business growth & traction would be talent and technology. They would continue to invest in the same over medium to long term which would drive the revenue.
๐Ÿ‘7๐Ÿ”ฅ2โšก1๐Ÿ‘Œ1
#Future #Plans

โ€ข In CY23, wholesale bank credit is expected to maintain its growth trajectory in comparison to the past two years, supported by continuing economic recovery and higher working capital funding requirements in an inflationary environment. โ€ข Beyond the credit growth certain structural changes from SEBI like framework for AA and above rated companies to borrow 25% from the bond market, incentives from RBI to corporates to borrow from bond market rather than banks, could auger well for the bond market. โ€ข This year has another geopolitical risk in the form of elections in more than 60 countries, including US. The outcome of these elections has potential to impact global business sentiments. โ€ข They would make accelerated investment towards talent and technology. โ€ข They would also continue to focus on customer centric innovation and solutions which would address the niche needs of their clients. โ€ข They continue to focus on expanding their reach to Tier 2 & Tier 3 institutions through its partnership channels in the research division. โ€ข They anticipate the capital market issuances will revive in the H2 CY24 with softening interest rates and gradual revival of private sector capex. โ€ข As majority of the revenue is generated outside India, so the company faces the currency risk which would be a key monitorable factor going forward. โ€ข They continue to drive opportunity in emerging markets, Middle East, South Asia and Africa for the infrastructure advisory space. They are also in discussion across multilateral agencies and different countries to increase investments on infrastructure. โ€ข The ESG rating is likely an opportunity for the company in the ratings business, going forward.
๐Ÿ”ฅ7๐Ÿ‘3โค2๐Ÿ‘Œ2
CRISIL 4800-5240
Expected level 6000
Support 4400
๐Ÿ‘13๐Ÿ”ฅ5โšก4๐Ÿ‘Œ3
Tata Consumer 870-970
Expected level 1200
Support 800
โšก19๐Ÿ‘7๐Ÿ”ฅ5โค2๐Ÿ‘Œ2
Nuclear Energy Stocks in India ๐Ÿญ

1.NTPC โ€“ builds Nuclear Power Plants 

2.BHEL - builds Nuclear Power Plants

3.Hindustan Construction Company (HCC) - builds Nuclear Power Plants

4.MTAR Tech - makes components for Nuclear Reactors 

5.Power Mech Projects โ€“ makes components for Nuclear Reactors 

6.Walchandnagar Industries - makes components for Nuclear Reactors 

7.  Kirloskar brother: Global leader in manufacturing pumps for nuclear power plants
๐Ÿ”ฅ17๐Ÿ‘9โšก2
Good morning
๐Ÿ‘4๐Ÿ•Š3๐Ÿพ2๐Ÿ†’1
Jefferies on Sun Pharma ๐Ÿ’Š

โ— Buy Call
: Target Price โ‚น2,150/share ๐Ÿ“ˆ
โ— Peak Sales: Latest cancer treatment assets could hit $100M ๐ŸŽฏ
โ— Other Trials: Indications still in trials, offering optional value ๐Ÿ”ฌ
โ— Sales Outlook: Peak sales seen as modest ๐Ÿ“‰
โ— Cost Leverage: Existing infra can commercialize products with minimal cost ๐Ÿญ
โ— NPV Impact: Combined NPV of $380M (<1% of market cap) ๐Ÿ’ผ
๐Ÿ‘8๐Ÿ”ฅ5โšก4๐Ÿซก2๐Ÿ’Š2
Motilal Oswal on RELIANCE INDUSTRIES โšก

โ— Buy Call
: Target Price โ‚น1,580/share ๐Ÿ“ˆ
โ— Risk-Reward: Compelling with improving FCF generation ๐Ÿ’ฐ
โ— Reliance Jio: Tariff hikes, market share gains, and FWA ramp-up to drive growth ๐Ÿ“ก
โ— Reliance Retail: Growth recovery critical for re-rating ๐Ÿ›’
โ— O2C: Refining margin recovery underway; Petchem remains soft ๐Ÿ›ข๏ธ
๐Ÿ”ฅ9๐Ÿ‘6๐Ÿ‘Œ3โšก2
Motilal Oswal on Tata Power โšก

โ— Buy Call
: Target Price โ‚น509/share ๐Ÿ“ˆ
โ— Growth Vision: EBITDA & PAT to double by FY30 ๐Ÿš€
โ— Renewables Focus: Share in PAT to rise to ~50% by FY30 (FY24: 21%) ๐ŸŒž
โ— Decline in Coal: Conventional generation & coal share to drop to 11% by FY30 ๐Ÿญ
โ— Capex Surge: โ‚น1.46 lakh crore planned over 5 years, 3x the previous period ๐Ÿ’ธ
๐Ÿ‘10๐Ÿ”ฅ4โšก3๐Ÿ‘Œ3โค1